About Us
Enabling life-science labs to accelerate discoveries that change lives
BICO strives towards the vision to enable life-science labs to accelerate the discoveries that change lives. We do this by leveraging a global portfolio of pioneering brands fusing automation, intelligence, and data to unlock scientific discovery at scale. Our portfolio ranges from Biosero’s market-leading Green Button Go lab orchestration software to off-the shelf automated lab instruments.
Pharma and biotech companies face the same fundamental challenge: long, costly development cycles for new therapies. BICO exists so therapies reach humanity sooner. We serve as the catalyst for a truly connected era of life sciences – where technology, data, and human potential move together in seamless flow, turning every result into the next discovery, and every discovery into a new possibility.
Together, we enable our customers to deliver what matters most – the discoveries that advance human health.
Mission
Leverage a global portfolio of pioneering brands fusing automation, intelligence, and data to unlock scientific discovery at scale.
Vision
BICO enables life-science labs to accelerate the discoveries that change lives.
OUR STORY
BICO was founded as CELLINK in the spring of 2015 in Gothenburg, Sweden, by Erik Gatenholm and Héctor Martínez. The company was built on research at Chalmers University of Technology, where Professor Paul Gatenholm had developed revolutionary bioinks. Bioinks are hydrogel-based materials that allow living human cells to be printed into 3D structures using bioprinting. In January 2016 the official company was registered with the joining of Jockum Svanberg, Ida Henriksson, and Gusten Danielsson.
Erik Gatenholm recognized the global commercial potential of the technology and teamed up with Hector Martínez to create a technology company that would make 3D bioprinting accessible to researchers around the world by offering bioprinters, bioinks, and user-friendly software. Their breakthrough was the development of the first universal bioink that could be used with a wide range of bioprinters. This innovation democratized bioprinting by lowering both cost and technical barriers for labs interested in tissue engineering, drug discovery, and regenerative medicine.
CELLINK quickly gained international recognition, went public on the Nasdaq First North in 2016, less than a year after its founding, and expanded through both organic development and acquisitions by listening to the customer needs and expanding the portfolio through strategic acquisitions. In 2021, CELLINK rebranded to BICO Group AB.
OUR VALUES
Trust
The foundation of everything we do. We build trust by fostering transparency, acting with integrity, and holding ourselves and each other accountable.
Focus
Knowing what matters most. We prioritize the goals and actions that create the greatest impact, staying committed to what drives our success.
Collaboration
Achieving more together. By working as one team, sharing knowledge, and supporting each other, we unlock our full potential and drive meaningful results across the organization.
Grit
The determination to succeed. We face challenges with passion, perseverance, and resilience, staying motivated and committed to our mission, no matter the obstacles.
Learn More
Explore what it is like to work at BICO, and our open opportunities across BICO and our portfolio brands.
